Freeze away stomach bleeding: new spray trial offers hope
NCT ID NCT07169799
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a cryotherapy spray (Tru-Freeze) to treat gastric antral vascular ectasia (GAVE), a condition that causes bleeding in the stomach. Researchers will measure changes in hemoglobin levels and blood transfusion needs in 50 adults over 6 months. The goal is to see if the spray can reduce bleeding and improve quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ANTRAL VASCULAR ECTASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.